TAS-116 (Pimitespib): Mechanism of Action

TAS-116 (Pimitespib) MOA:Targeting HSP90/Receptor Tyrosine Kinase Pathway for Gastrointestinal Stromal Tumor

🎯 check TAS-116 (Pimitespib) product page

TAS-116 (Pimitespib) is a selective HSP90 inhibitor. It affects EGFR, KIT, and AKT/MAPK signaling pathways by decreasing client protein levels, effectively inhibiting cancer cell proliferation and inducing apoptosis.

Primary Applications and Mechanism of Action